[go: up one dir, main page]

EE05293B1 - RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine - Google Patents

RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine

Info

Publication number
EE05293B1
EE05293B1 EEP200200323A EEP200200323A EE05293B1 EE 05293 B1 EE05293 B1 EE 05293B1 EE P200200323 A EEP200200323 A EE P200200323A EE P200200323 A EEP200200323 A EE P200200323A EE 05293 B1 EE05293 B1 EE 05293B1
Authority
EE
Estonia
Prior art keywords
polypeptides
immunoconjugate
binding antibody
peptide binding
pol peptide
Prior art date
Application number
EEP200200323A
Other languages
English (en)
Estonian (et)
Inventor
Harkins Richard
Parkes Deborah
Parry Gordon
W. Schneider Douglas
Steinbrecher Renate
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200323A publication Critical patent/EE200200323A/xx
Publication of EE05293B1 publication Critical patent/EE05293B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
EEP200200323A 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine EE05293B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (fr) 1999-12-16 2000-12-15 Adn codant un nouveau polypeptide rg1

Publications (2)

Publication Number Publication Date
EE200200323A EE200200323A (et) 2003-10-15
EE05293B1 true EE05293B1 (et) 2010-04-15

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200323A EE05293B1 (et) 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine

Country Status (32)

Country Link
US (5) US6682902B2 (fr)
EP (2) EP2048157B1 (fr)
JP (1) JP4979867B2 (fr)
KR (1) KR100752434B1 (fr)
CN (1) CN1297566C (fr)
AT (1) ATE440862T1 (fr)
AU (1) AU784674B2 (fr)
BG (1) BG65898B1 (fr)
BR (1) BR0017022A (fr)
CA (1) CA2394574A1 (fr)
CZ (1) CZ299232B6 (fr)
DE (1) DE60042836D1 (fr)
DK (1) DK1237915T3 (fr)
EE (1) EE05293B1 (fr)
ES (1) ES2331106T3 (fr)
HR (1) HRP20020549B1 (fr)
HU (1) HU229001B1 (fr)
IL (2) IL150115A0 (fr)
LT (1) LT5046B (fr)
ME (1) MEP37808A (fr)
MX (1) MXPA02005914A (fr)
NO (1) NO330924B1 (fr)
NZ (1) NZ519598A (fr)
PL (1) PL207634B1 (fr)
PT (1) PT1237915E (fr)
RO (1) RO122543B1 (fr)
RS (1) RS50831B (fr)
RU (1) RU2283130C2 (fr)
SI (2) SI1237915T1 (fr)
SK (2) SK286384B6 (fr)
WO (1) WO2001044291A2 (fr)
ZA (1) ZA200205638B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
JP4680902B2 (ja) * 2003-07-22 2011-05-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Ｒｇ１抗体及びその使用
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI610939B (zh) * 2007-02-21 2018-01-11 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
CA2707443A1 (fr) * 2007-11-30 2009-06-11 Bristol-Myers Squibb Company Conjugues d'anticorps anti-rg-1
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
JP2938569B2 (ja) 1990-08-29 1999-08-23 ジェンファーム インターナショナル，インコーポレイティド 異種免疫グロブリンを作る方法及びトランスジェニックマウス
WO1993023057A1 (fr) 1992-05-14 1993-11-25 Ribozyme Pharmaceuticals, Inc. Procede et reactif destines a empecher l'evolution du cancer
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6177244B1 (en) 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US6287777B1 (en) 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
US6432636B1 (en) * 1996-08-26 2002-08-13 University Of Washington Diagnostic applications of perlecan domain I splice variants
AU6961398A (en) 1997-04-10 1998-10-30 Zymogenetics Inc. Secreted f-spondin homologs
WO1998050555A2 (fr) * 1997-05-06 1998-11-12 Human Genome Sciences, Inc. POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS)
AU7376698A (en) 1997-05-09 1998-11-27 Smithkline Beecham Corporation Integrin ligand, human mindin
ES2312205T3 (es) 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
JP2002527757A (ja) * 1998-10-19 2002-08-27 ダイアデクスアス・インコーポレーテッド 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6682736B1 (en) * 1998-12-23 2004-01-27 Abgenix, Inc. Human monoclonal antibodies to CTLA-4
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
US20040152139A1 (en) 2004-08-05
DK1237915T3 (da) 2009-11-16
US7307154B2 (en) 2007-12-11
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
WO2001044291A2 (fr) 2001-06-21
IL150115A0 (en) 2002-12-01
RU2002119208A (ru) 2004-02-27
US6682902B2 (en) 2004-01-27
AU784674B2 (en) 2006-05-25
CN1434832A (zh) 2003-08-06
JP2003521244A (ja) 2003-07-15
JP4979867B2 (ja) 2012-07-18
RO122543B1 (ro) 2009-08-28
SI21140A (sl) 2003-08-31
CN1297566C (zh) 2007-01-31
SK8482002A3 (en) 2003-02-04
HUP0204224A2 (hu) 2003-03-28
PL207634B1 (pl) 2011-01-31
EP1237915B1 (fr) 2009-08-26
NZ519598A (en) 2004-03-26
US20020004047A1 (en) 2002-01-10
LT2002070A (en) 2003-04-25
HRP20020549B1 (hr) 2013-09-30
ATE440862T1 (de) 2009-09-15
NO20022836D0 (no) 2002-06-14
ES2331106T3 (es) 2009-12-22
EP1237915A2 (fr) 2002-09-11
US20090214422A1 (en) 2009-08-27
MXPA02005914A (es) 2003-02-27
NO20022836L (no) 2002-08-15
US20040023307A1 (en) 2004-02-05
SK286384B6 (sk) 2008-08-05
HRP20020549A2 (en) 2004-04-30
EP2048157B1 (fr) 2012-10-10
WO2001044291A3 (fr) 2002-01-17
KR100752434B1 (ko) 2007-08-27
US7887804B2 (en) 2011-02-15
BG106823A (bg) 2003-04-30
IL150115A (en) 2013-11-28
HUP0204224A3 (en) 2004-12-28
US20090292112A1 (en) 2009-11-26
PL356220A1 (en) 2004-06-28
US7893217B2 (en) 2011-02-22
LT5046B (lt) 2003-08-25
YU44602A (sh) 2005-06-10
AU3074601A (en) 2001-06-25
NO330924B1 (no) 2011-08-22
HU229001B1 (en) 2013-07-29
SI1237915T1 (sl) 2009-12-31
EP2048157A1 (fr) 2009-04-15
EE200200323A (et) 2003-10-15
ZA200205638B (en) 2003-10-15
CZ299232B6 (cs) 2008-05-21
MEP37808A (en) 2011-05-10
SK288147B6 (sk) 2013-12-02
RU2283130C2 (ru) 2006-09-10
DE60042836D1 (de) 2009-10-08
KR20020065575A (ko) 2002-08-13
CA2394574A1 (fr) 2001-06-21
BG65898B1 (bg) 2010-04-30
BR0017022A (pt) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE454159T1 (de) Von survivin abgeleitete peptide und deren verwendung
EE05212B1 (et) Polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on m?eldud kasvajaraku raviks, mis ekspresseerib APRIL-i
EE05293B1 (et) RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine
NO20005296D0 (no) CD19xCD3-spesifikke polypeptider og anvendelser derav
DE69630710D1 (de) Humaner tumornekrosefaktor delta und epsilon
DE60127143D1 (de) Bispezifische Antikörper gegen CD19 und CD16 und deren Verwendung
WO2004069876A3 (fr) Reponse de lymphocyte t durable
FI954536A0 (fi) Eristettyjä nukleiinihappomolekyylejä, jotka koodittavat kasvainhyljintäantigeenin esiastetta MAGE-3, ja niiden hyötykäyttö
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
DE60032486D1 (de) Prion protein peptide und deren verwendung
DE69434384D1 (de) Metalkomplexbildner
NO20011460L (no) Cytokinreseptor zalphall
DE60118359D1 (de) Humanische pellino-polypeptide
DK1354054T3 (da) Polypeptider der kan binde til CD64, og som omfatter en eller flere heterologe T-celle-epitoper, samt anvendelser deraf
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
ES2150937T3 (es) Autotaxina: proteina estimulante de la motilidad util en el diagnostico y terapia del cancer.
WO2002014369A3 (fr) Polypeptides du domaine d5 humain de production de kinine s
WO2004020591A3 (fr) Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides
HK1048495A1 (zh) 脱氧核糖核酸编码的prost07多肽
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
DE69631624D1 (de) Antikörper gegen menschliches restrictin
WO2004039952A3 (fr) Procedes d'utilisation de polypeptides humains codes par des polynucleotides
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
ATE323162T1 (de) Menschliche neurexin-ähnliche proteine und dafür kodierende polynukleotide

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20141215